Anta Gkelou

Anta Gkelou

Director/Board Member at France Invest

38 year
Finance
Consumer Services
Health Technology

Profile

Anta joined us in 2017 and is a principal with the Capital Strategy.
She was previously an immunology scientist at Danone Nutricia, where she was involved in translational research and development of prebiotic and probiotic products for immune resilience.
Anta completed her Ph.D.
at the National Heart and Lung Institute of Imperial College in London in collaboration with Pfizer UK, where she studied the biology of oxidative stress-driven steroid insensitivity in COPD.
She continued her post-doctoral studies at the National Institute of Health of France, INSERM, where she investigated the molecular and cellular mechanisms that regulate cardiomyocyte function post myocardial infarction at the European Hospital George Pompidou in Paris.

Anta Gkelou active positions

CompaniesPositionStart
Private Equity Investor 2020-08-31
Director/Board Member 2021-08-31
All active positions of Anta Gkelou

Former positions of Anta Gkelou

CompaniesPositionEnd
Director/Board Member 2022-11-03
See the detail of Anta Gkelou's experience

Training of Anta Gkelou

Imperial College London Doctorate Degree
University of Liverpool Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anta Gkelou's experience

Connections

99

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies3

Finance

Health Technology

Finance

See company connections